OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
Akihiro Morinaka, David M. Livermore(University of East Anglia)
Cited by 167
Related Papers
Outbreak of Infections Caused by <i>Pseudomonas aeruginosa</i> Producing VIM-1 Carbapenemase in Greece
|Journal of Clinical Microbiology|2000|261
The threat from the pink corner
|Annals of Medicine|2003|93
Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16
|Journal of Antimicrobial Chemotherapy|2017|76
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
|Journal of Antimicrobial Chemotherapy|2015|65
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli
|International Journal of Antimicrobial Agents|2023|55